Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine

Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine

Intramuscular vaccines have greatly reduced hospitalization and death due to severe COVID-19. However, most countries are experiencing a resurgence of infection driven predominantly by the Delta and Omicron variants of SARS-CoV-2. In response, booster dosing of COVID-19 vaccines has been implemented...

Full description

Bibliographic Details
Main Authors: Bitko, V. (Author), Chen, C. (Author), Chuang, Y.-S (Author), Fattom, A. (Author), Ganesan, S. (Author), Kuo, T.-Y (Author), Lien, C.-E (Author), Lin, M.-Y (Author), Lin, Y.-J (Author), Liu, L.T.-C (Author)
Format: Article
Language:English
Published: Nature Research 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items